- Home
- IVA vs MIY Comparison
IVA vs MIY Comparison
Compare IVA & MIY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVA
- MIY
- Stock Information
- Founded
- IVA 2011
- MIY 1992
- Country
- IVA France
- MIY United States
- Employees
- IVA N/A
- MIY N/A
- Industry
- IVA Biotechnology: Pharmaceutical Preparations
- MIY Investment Bankers/Brokers/Service
- Sector
- IVA Health Care
- MIY Finance
- Exchange
- IVA Nasdaq
- MIY Nasdaq
- Market Cap
- IVA 359.6M
- MIY 313.7M
- IPO Year
- IVA 2020
- MIY N/A
- Fundamental
- Price
- IVA $4.36
- MIY $11.20
- Analyst Decision
- IVA Strong Buy
- MIY
- Analyst Count
- IVA 4
- MIY 0
- Target Price
- IVA $10.50
- MIY N/A
- AVG Volume (30 Days)
- IVA 29.2K
- MIY 56.8K
- Earning Date
- IVA 09-24-2025
- MIY 01-01-0001
- Dividend Yield
- IVA N/A
- MIY 3.98%
- EPS Growth
- IVA N/A
- MIY N/A
- EPS
- IVA N/A
- MIY N/A
- Revenue
- IVA $14,591,573.00
- MIY N/A
- Revenue This Year
- IVA $44.22
- MIY N/A
- Revenue Next Year
- IVA $24.23
- MIY N/A
- P/E Ratio
- IVA N/A
- MIY N/A
- Revenue Growth
- IVA N/A
- MIY N/A
- 52 Week Low
- IVA $1.53
- MIY $9.45
- 52 Week High
- IVA $4.36
- MIY $11.70
- Technical
- Relative Strength Index (RSI)
- IVA 74.37
- MIY 60.15
- Support Level
- IVA $3.44
- MIY $10.62
- Resistance Level
- IVA $3.58
- MIY $11.31
- Average True Range (ATR)
- IVA 0.30
- MIY 0.11
- MACD
- IVA 0.11
- MIY 0.03
- Stochastic Oscillator
- IVA 100.00
- MIY 74.58
About IVA Inventiva S.A. American Depository Shares
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.
About MIY Blackrock MuniYield Michigan Quality Fund Inc.
Blackrock Muniyield Michigan Quality Fund Inc is a closed end fund. Its investment objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes and New York State and New York City personal income taxes as is consistent with its investment policies and prudent investment management.